Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bedrock Bioscience is a healthcare company specializing in the development and distribution of medical-grade red light therapy devices and nutritional supplements. The company primarily focuses on providing non-invasive treatment options for peripheral neuropathy, chronic pain, and inflammatory conditions. Their product line includes clinical-strength infrared light pads designed to increase microcirculation and specialized nerve support formulas that provide essential nutrients for nerve health. Bedrock Bioscience serves both healthcare practitioners and individual patients, offering tools for use in clinical settings and for home-based therapy. The company's approach integrates photobiomodulation technology with targeted nutrition to manage symptoms of nerve damage and improve patient quality of life. Their solutions are widely used in chiropractic and physical therapy clinics across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bedrock Bioscience.